ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/13/2026
Back to search
Official data from USPTO
PARSORTIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PARSORTIX
ST13
US500000087140221Class
1, 5, 9, 10
Filing
87140221
Registration
5425872
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
05/14/2026
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
08/16/2016
Registration date
03/20/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/28/2025
Last transaction
05/14/2026
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
11
Owner location
GUILDFORD, GB
Examiner
LEE, IN PYO
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CELLBXHEALTH EUROPE LIMITED
Angle Europe Limited
Representatives
Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparations and reagents for scientific or research use; Chemical reagents for non-medical purposes; reagents for in vitro use for scientific or medical research; buffer solutions and reagents for use in diagnostic analysis and research with laboratory apparatusseparation apparatus and analysis apparatus; biomarkersnucleic acidprotein and other biochemical ligands for scientific or research use; diagnostic kits comprised of diagnostic reagents and assay components for clinical and medical laboratory use
Class 5
Medical diagnostic reagents and assay components for testing of body fluids including blood and plasmacells; medical diagnostic kits comprised of diagnostic reagents and assay components for testing of body fluids including blood and plasmacells for medical purposes; all the aforesaid goods not including any such goods that are prescription only pharmaceuticals; biomarkersdiagnostic biomarker reagents for medical purposes; diagnostic reagent kits consisting primarily of medical diagnostic reagents and assaysfor use in detecting cancerous conditions and other conditions involving somatic genetic changes; medical testing kits comprising reagents to assay biochemicals including nucleic acids and proteinsfor use in detecting cancerous conditions and other conditions involving somatic genetic changes for medical purposes
Class 9
Apparatusequipment and instruments for scientificlaboratorydiagnostic or general research uselaboratory vesselsanalyzerspre-packed columns for use in separation and purificationglasswaretubes including sample tubesreagent tubes; phlebotomy tubes and eppendorf tubes; apparatusequipment and instruments for cytologyhistology and for use in detecting cancerous conditions for laboratory or research use; apparatus in the nature of cassettes for use in laboratorydiagnostic or general research use; cell analyzer providing quantitative cell analysis for scientificlaboratory or general research use and disposable cassettes therefor; apparatus for use in testing and analyzing blood and blood cells for laboratory or research use; biological analysis computer software; parts and fitting for the aforesaid goods; medical laboratory research instruments for use in the detection of cancer
Class 10
Medical diagnostic apparatusequipment and instruments for diagnosis of clinical conditions involving the presence of solid tissue cells in blood; medical testing apparatusequipment and instrumentsmedical diagnostic apparatus for testing body fluids including blood and plasmacancer cells; fetal cells; parts and fittings for the aforesaid goods; diagnostic apparatusequipment and instruments for cytology and histologyall for use in detecting cancer
Publications
History of USPTO decisions and trademark events.
47 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/28/2025
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
03/28/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/28/2025
ES8R
TEAS SECTION 8 RECEIVED
08/22/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/20/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/20/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/02/2018
PUBO
PUBLISHED FOR OPPOSITION
01/02/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/13/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/29/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
11/21/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/21/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
11/21/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/21/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/14/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/07/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/26/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/17/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
10/16/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/16/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
10/16/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/16/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/10/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/26/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/12/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
09/11/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/11/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
09/11/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/23/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/23/2017
ALIE
ASSIGNED TO LIE
08/22/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/07/2017
GNRT
NON-FINAL ACTION E-MAILED
03/07/2017
CNRT
NON-FINAL ACTION WRITTEN
03/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/10/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/06/2016
GNRT
NON-FINAL ACTION E-MAILED
12/06/2016
CNRT
NON-FINAL ACTION WRITTEN
12/06/2016
DOCK
ASSIGNED TO EXAMINER
11/28/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/19/2016
NWAP
NEW APPLICATION ENTERED
08/19/2016
Continuous trademark protection
Get notified about every new filing that threatens PARSORTIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.